| EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Ann Rheum Dis. 69 (6), 1103, 2010 | 893 | 2010 |
| Accelerated atherosclerosis in autoimmune rheumatic diseases Y Shoenfeld, R Gerli, A Doria, E Matsuura, MM Cerinic, N Ronda, LJ Jara, ... Circulation 112 (21), 3337-3347, 2005 | 748 | 2005 |
| Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European … C Vitali, S Bombardieri, HM Moutsopoulos, J Coll, R Gerli, PY Hatron, ... Annals of the rheumatic diseases 55 (2), 116-121, 1996 | 597 | 1996 |
| Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity G Vaudo, S Marchesi, R Gerli, R Allegrucci, A Giordano, D Siepi, M Pirro, ... Annals of the rheumatic diseases 63 (1), 31-35, 2004 | 421 | 2004 |
| Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial C Ferri, E Marzo, G Longombardo, F Lombardini, L La Civita, R Vanacore, ... Blood 81 (5), 1132, 1993 | 362 | 1993 |
| CD4+ CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients R Gerli, G Schillaci, A Giordano, EB Bocci, O Bistoni, G Vaudo, ... Circulation 109 (22), 2744-2748, 2004 | 318 | 2004 |
| Prednisone plus Methotrexate for Polymyalgia Rheumatica: a randomized double blind, placebo-controlled trial R Caporali, MA Cimmino, G Ferraccioli, R Gerli, C Klersy, C Salvarani, ... Annals of Internal Medicine 141, 493-500, 2004 | 257 | 2004 |
| Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients C Baldini, P Pepe, L Quartuccio, R Priori, E Bartoloni, A Alunno, ... Rheumatology 53 (5), 839-844, 2014 | 246 | 2014 |
| Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived … C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 227 | 2007 |
| Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. PL Salvarani, C Manzini, G Paolazzi, A Trotta, P Manganelli, M Cimmino, ... Ann. Intern. Med. 146 (9), 631-9, 2007 | 217 | 2007 |
| Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy F Salaffi, M Carotti, A Iagnocco, F Luccioli, R Ramonda, E Sabatini, ... Rheumatology 47 (8), 1244-1249, 2008 | 206 | 2008 |
| COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy C Perricone, E Bartoloni, R Bursi, G Cafaro, GM Guidelli, Y Shoenfeld, ... Immunologic research 68, 213-224, 2020 | 202 | 2020 |
| Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study F Carubbi, P Cipriani, A Marrelli, PD Benedetto, P Ruscitti, O Berardicurti, ... Arthritis research & therapy 15, 1-15, 2013 | 197 | 2013 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 191 | 2012 |
| Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new A Alunno, E Bartoloni, O Bistoni, G Nocentini, S Ronchetti, S Caterbi, ... Clinical and Developmental Immunology 2012, 2012 | 186 | 2012 |
| Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. V Bocci, G Valacchi, F Corradeschi, C Aldinucci, S Silvestri, E Paccagnini, ... Journal of biological regulators and homeostatic agents 12 (3), 67-75, 1998 | 186 | 1998 |
| Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. L Mancarella, F Bobbio-Pallavicini, F Ceccarelli, PC Falappone, ... The Journal of rheumatology 34 (8), 1670-1673, 2007 | 180 | 2007 |
| Precocious intimamedia thickening in patients with primary Sjögren's syndrome G Vaudo, EB Bocci, Y Shoenfeld, G Schillaci, R Wu, N Del Papa, C Vitali, ... Arthritis & Rheumatism 52 (12), 3890-3897, 2005 | 175 | 2005 |
| Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection A Bertotto, R Gerli, F Spinozzi, C Muscat, F Scalise, G Castellueei, ... European journal of immunology 23 (5), 1177-1180, 1993 | 168 | 1993 |
| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 164 | 2017 |
